News tagged with therapeutic option
New drug targets skin cancer
A new class of drug targeting skin cancer's genetic material has been successfully tested in humans for the first time, opening the way to new treatments for a range of conditions from skin cancers to eye ...
Cancer
May 07, 2013 |
5 / 5 (1) |
0
Study finds possible alternative to bariatric weight loss surgery
An experimental procedure successfully tested in obese laboratory rats may provide a less-invasive alternative to bariatric weight-loss surgery, researchers report online in Endocrinology.
Surgery
Apr 30, 2013 |
not rated yet |
0
Liver cancers armed with many strategies for evading immune response
(Medical Xpress)—Researchers at Roswell Park Cancer Institute (RPCI) have published findings that help explain how a common and particularly resilient form of liver cancer evades the body's natural antitumor responses. ...
Cancer
Apr 18, 2013 |
not rated yet |
0
Treatment for novel coronavirus shows promise in early lab tests
National Institutes of Health (NIH) scientists studying an emerging coronavirus have found that a combination of two licensed antiviral drugs, ribavirin and interferon-alpha 2b, can stop the virus from replicating ...
Diseases, Conditions, Syndromes
Apr 18, 2013 |
not rated yet |
0
Gene regenerates heart tissue, critical finding for heart failure prevention
Researchers at UT Southwestern Medical Center have identified a specific gene that regulates the heart's ability to regenerate after injuries.
Genetics
Apr 17, 2013 |
4.7 / 5 (3) |
0
|
Genetic variation contributes to pulmonary fibrosis risk
A newly published study of patients with pulmonary fibrosis has discovered multiple genetic variations that should help with future efforts to treat the disease.
Genetics
Apr 15, 2013 |
not rated yet |
0
|
Experimental study suggests bone-marrow grafts show promise for some sufferers of low-back pain
A new study suggests that the type of bio-cellular grafts increasingly used by surgeons to repair damaged tissue may be useful for treating low-back pain (LBP). However, not all sufferers responded equally to the novel therapy. ...
Diseases, Conditions, Syndromes
Apr 11, 2013 |
not rated yet |
0
Genetic biomarker may help identify neuroblastomas vulnerable to novel class of drugs
An irregularity within many neuroblastoma cells may indicate whether a neuroblastoma tumor, a difficult-to-treat, early childhood cancer, is vulnerable to a new class of anti-cancer drugs known as BET bromodomain inhibitors, ...
Cancer
Apr 09, 2013 |
not rated yet |
0
Individualized genomic testing allows for tailored cancer treatment, new drug research
Just like a massive iceberg jutting out of the ocean, many of cancer's genetic underpinnings remain hidden under the surface, impossible to predict or map from above. The foreboding shadows and shapes that appear on CT scans ...
Cancer
Apr 05, 2013 |
not rated yet |
0
Biomarker may identify neuroblastomas with sensitivity to BET bromodomain inhibitors
Neuroblastoma, the most common malignant tumor of early childhood, is frequently associated with the presence of MYCN amplification, a genetic biomarker associated with poor prognosis. Researchers have determined that tumors ...
Cancer
Feb 21, 2013 |
not rated yet |
0
Cure in sight for kissing bug's bite
Chagas disease, a deadly tropical infection caused by the protozoan parasite Trypanosoma cruzi and transmitted by biting insects called "kissing bugs," has begun to spread around the world, including the U.S. Yet current treatm ...
Medications
Feb 14, 2013 |
not rated yet |
0
Researchers discover biological diversity in triple-negative breast cancer
Triple-negative breast cancers are more biologically diverse than previously believed and classification should be expanded to reflect this heterogeneity, according to University of North Carolina researchers.
Cancer
Feb 13, 2013 |
not rated yet |
0
|
Northwestern Medicine researchers investigate stem cell therapy for stroke
Each year, nearly 800,000 Americans suffer a stroke which can result in permanent brain damage, long term disability or death. As a leading cause of adult disability, stroke has an annual burden of more than $62 billion on ...
Medical research
Feb 11, 2013 |
not rated yet |
0
The factor that could influence future breast cancer treatment
Australian scientists have shown in the laboratory how a 'transcription factor' causes breast cancer cells to develop an aggressive subtype that lacks sensitivity to estrogen and does not respond to known anti-estrogen therapies. ...
Cancer
Dec 27, 2012 |
not rated yet |
0
Understanding of infantile hemangiomas is improving
(HealthDay)—Improved understanding of the pathogenesis of infantile hemangiomas (IHs) is leading to better treatment options, according to a review published online Dec. 24 in Pediatrics.
Pediatrics
Dec 27, 2012 |
not rated yet |
0
